Form 8-K - Current report:
SEC Accession No. 0001437749-21-014944
Filing Date
2021-06-16
Accepted
2021-06-16 16:16:47
Documents
1
Period of Report
2021-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20210615_8k.htm 8-K 27119
  Complete submission text file 0001437749-21-014944.txt   28429
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 211021706
SIC: 2834 Pharmaceutical Preparations